ACR Convergence 2025| Tips for Starting Your Own Rheumatology Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hip OA

ACR Releases COVID-19 Clinical Guidance for Pediatric Patients with Rheumatic Disease

Gretchen Henkel  |  July 8, 2020

The recommendations for pediatric rheumatology patients address various treatment options and provide general guidance, as well as direction for when to start, stop or reduce medications.

Filed under:Conditions Tagged with:COVID-19Dawn WaheziJay MehtaPediatric Rheumatology

Bone Density Concerns: Guidance on Tackling Fracture Risk in CKD

Thomas R. Collins  |  July 7, 2020

Suggestions on how to assess risk and manage bone issues in chronic kidney disease patients are offered…

Filed under:ConditionsEULAR/OtherMeeting ReportsOsteoarthritis and Bone Disorders Tagged with:bone mineral density (BMD)chronic kidney diseaseEULARfracture riskFractureskidneyOsteoporosisosteoporosis treatments

The ACR Releases New Telemedicine Position Statement

Carina Stanton  |  July 6, 2020

The rapid expansion of telemedicine in rheumatology, as well as changes to reimbursement and relaxed regulations, during the COVID-19 pandemic has served as an impetus for the ACR to review its position and release a new statement in support of optimized telemedicine practices.

Filed under:Practice Support Tagged with:COVID-19telemedicine

In Memoriam … J. Timothy Harrington, MD, MACR: July 6, 1940–June 23, 2020

William Arnold, MD; Tim Bartholow, MD; Drew Johnson, MS, MBA; Joel Kremer, MD; Daniel Malone, MD; Eric D. Newman, MD; Kenneth Saag, MD; & Douglas White, MD  |  June 30, 2020

June saw the passing of a beloved colleague, mentor and friend to many in the rheumatology community when J. Timothy Harrington, MD, died of pancreatic cancer in his hometown of Madison, Wis. Dr. Harrington trained at Massachusetts General Hospital, the National Institutes of Health National Cancer Institute and UT Southwestern Medical Center, and served on…

Filed under:Professional TopicsProfiles Tagged with:Dr. J. Timothy HarringtonHarrington

Unified Signature of SLE May Advance Clinical Diagnosis & Biomarker Development

Lara C. Pullen, PhD  |  June 29, 2020

Researchers have identified 93 genes that may play a role in systemic lupus erythematosus (SLE), including 47 genes not previously associated with SLE. Theresulting transcriptome has revealed underappreciated genes and pathways associated with the pathogenesis of SLE…

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:BiomarkersDiagnosissystemic lupus erythematosus (SLE)

Basilisks in Rheumatology: The Hunt for Rheumatic Mysteries Shrouded in Enigmas & Wrapped in Puzzles

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  June 23, 2020

What do rheumatology and wizardry have in common? More than you may think. Like basilisks, rheumatic diseases are often elusive and changing in presentation…

Filed under:Professional Topics

More Money, More Research: Foundation Report Sheds Light on Funding Gaps

Carina Stanton  |  June 23, 2020

The ACR and Rheumatology Research Foundation hope a new report on rheumatic disease research can leverage more money for ACR members, funding future research…

Filed under:Professional TopicsResearch Rheum Tagged with:COVID-19FundingResearchRheumatology Research Foundation

Florida Society of Rheumatology in the Spotlight

Linda Childers  |  June 18, 2020

Advocacy efforts on access and workforce issues in Florida are discussed.

Filed under:Professional Topics Tagged with:Dr. Guillermo ValenzuelaDr. Reshma KhanFlorida Society of Rheumatologystate society

Dr. Kawasaki

Tomisaku Kawasaki, Pediatrician Who Discovered Disease That Bears His Name, Dies at 95

Renée Bacher  |  June 18, 2020

Japanese pediatrician Tomisaku Kawasaki, MD, who identified an inflammatory syndrome that affects children, died on June 5 in Tokyo. He was 95. Tenacity & Attention to Detail Born Feb. 7, 1925, in Tokyo, Dr. Kawasaki graduated from medical school at what is now Chiba University in Chiba, Japan, in 1948 and worked as staff pediatrician…

Filed under:Professional TopicsProfiles Tagged with:KawasakiKawasaki diseaseTomisaku Kawasaki

Lupus Nephritis: Understanding the Paradigm for Treatment

Jason Liebowitz, MD, FACR  |  June 16, 2020

ACR BEYOND LIVE—Among patients with systemic lupus erythematosus (SLE), lupus nephritis remains one of the leading causes of mortality, and patients with both SLE and end-stage renal disease demonstrate standardized mortality ratios higher than 60 times that of patients with SLE who have normal kidney function.1 Although the ACR Guidelines for Screening, Treatment, and Management…

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:ACR State-of-the-Art Clinical SymposiumLupus nephritissystemic lupus erythematosus (SLE)

  • « Previous Page
  • 1
  • …
  • 124
  • 125
  • 126
  • 127
  • 128
  • …
  • 333
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences